Drinkwel, LLC – Trademark Portfolio

Entity Type: 16

Drinkwel, LLC holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 12 trademarks are registered. Notable registered marks include REVIL, DRINKWEL, LYTECAPS, LYTELINE, and LYTESHOW. The owner is based in Los Angeles, CA.

#638

3705 W Pico Blvd

Los Angeles, CA 900193541

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Drinkwel, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (19 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (6 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Drinkwel, LLC have?

Drinkwel, LLC has 19 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 abandoned, 5 cancelled.

What trademark classes does Drinkwel, LLC file in?

Drinkwel, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Drinkwel, LLC's most well-known trademarks?

Drinkwel, LLC's registered trademark portfolio includes well-known marks such as REVIL, DRINKWEL, LYTECAPS, LYTELINE, and LYTESHOW. These are among 12 currently registered trademarks in the portfolio.

What is Drinkwel, LLC's trademark registration success rate?

Drinkwel, LLC has a 63% trademark registration rate, with 12 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.